Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. R. Silver
Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents
Current Medical Research and Opinion
Medicine
Related publications
Managing Chemotherapy Induced Anemia With Darbepoetin Alfa and Other Erythropoiesis Stimulating Agents: A Nurse's Perspective
Nursing: Research and Reviews
Effects of Anemia Correction by Erythropoiesis-Stimulating Agents on Cardiovascular Function in Non-Dialysis Patients With Chronic Kidney Disease
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
Erythropoiesis-Stimulating Agents Increase the Risk of Acute Stroke in Patients With Chronic Kidney Disease
Kidney International
Nephrology
PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Beneficial Effect of High Dose Darbepoetin-Alfa in Peritoneal Dialysis Patients With Renal Anemia
Nihon Toseki Igakkai Zasshi
Treatment Options for Anemia, Taking Risks Into Consideration: Erythropoiesis-Stimulating Agents Versus Transfusions
Oncologist
Cancer Research
Medicine
Oncology
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update
Journal of Oncology Practice
Health Policy
Oncology
Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients With Cancer- Or Chemotherapy-Induced Anemia
Oncology
Medicine
Cancer Research
Oncology
Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia of Chronic Disease Associated With Cancer
British Journal of Cancer
Cancer Research
Oncology
